(Bloomberg) — People who received a fourth dose of the coronavirus vaccine saw a fivefold increase in antibodies one week after the injection, according to preliminary trial data from Israel.
“That suggests a much higher level of protection than without the shot, with regard to both infection and severe illness,” Prime Minister Naftali Bennett said Tuesday in a visit to Sheba Medical Center, which is conducting the trial.
Israel on Monday became the first country in the world to offer a fourth jab to people 60 and over to help beat back the omicron strain that has caused a surge in new cases. About 100,000 people in the country of nearly 9.5 million have already received the dose or made appointments for one, according to Bennett.
More stories like this are available on bloomberg.com
©2022 Bloomberg L.P.
